Cortisol Test: Stress Hormone Levels and Adrenal Function

Cortisol is the body's primary glucocorticoid — a steroid hormone produced by the adrenal cortex that governs the stress response, energy metabolism, immune function, blood pressure regulation, and the sleep-wake cycle. Because cortisol levels fluctuate dramatically throughout the day and in response to illness, stress, and medications, interpreting cortisol test results requires understanding not only the numeric value but the timing, method, and clinical context of the measurement. No single cortisol level tells the complete story.

Table of Contents

1. Overview
2. When Ordered
3. Reference Ranges
4. Testing Methods
5. Cushing's vs. Addison's Disease
6. HPA Axis Dysfunction
7. Circadian Rhythm of Cortisol
8. Stress Management and Cortisol Modulation
9. References

Overview

Cortisol is synthesized from cholesterol in the zona fasciculata of the adrenal cortex through a multi-step enzymatic process. Its production is tightly regulated by the hypothalamic-pituitary-adrenal (HPA) axis: the hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), which in turn drives the adrenal cortex to produce and release cortisol. Rising cortisol feeds back negatively to inhibit both CRH and ACTH secretion — a classic endocrine feedback loop.

Cortisol exerts its effects throughout the body:

• Metabolism: Stimulates gluconeogenesis (glucose production from non-carbohydrate substrates), promotes protein catabolism in muscle, and increases lipolysis — collectively ensuring fuel availability during stress
• Immune system: Broadly anti-inflammatory and immunosuppressive at pharmacological doses; modulates innate immunity at physiological levels
• Cardiovascular: Maintains blood pressure by potentiating the vasoconstrictive effects of catecholamines and regulating sodium and water balance
• Central nervous system: Influences mood, memory consolidation, arousal, and cognitive function
• Bone and connective tissue: Chronic excess cortisol suppresses osteoblast activity, reduces bone density, and impairs collagen synthesis

In blood, approximately 90% of cortisol is bound to corticosteroid-binding globulin (CBG) and albumin; only the free (unbound) fraction is biologically active. This distinction matters clinically because conditions that alter CBG levels (pregnancy, oral estrogen use, liver disease) affect total cortisol measurements without changing the bioactive free fraction.

When Ordered

Cortisol testing is ordered when clinical findings suggest abnormal adrenal function — either excessive cortisol production (hypercortisolism) or deficient production (hypocortisolism):

Suspected Hypercortisolism (Cushing's Syndrome)

• Central obesity with disproportionately thin extremities
• Moon face, buffalo hump, and supraclavicular fat pads
• Purple striae (stretch marks) on abdomen, thighs, and axillae
• Easy bruising, thin skin, poor wound healing
• Proximal muscle weakness
• Hypertension, hyperglycemia, and osteoporosis without clear alternative explanation
• Irregular menstrual cycles, hirsutism, and decreased libido

Suspected Hypocortisolism (Addison's Disease / Adrenal Insufficiency)

• Chronic fatigue, weakness, and weight loss
• Hyperpigmentation of skin and mucous membranes (primary adrenal insufficiency)
• Hypotension, particularly orthostatic
• Salt craving, hyponatremia, hyperkalemia
• Nausea, vomiting, abdominal pain, and anorexia
• Hypoglycemia, particularly in children
• Adrenal crisis: acute life-threatening collapse requiring emergency hydrocortisone

Other Indications

• Assessing HPA axis after glucocorticoid therapy (checking for suppression)
• Evaluating fatigue, mood disorders, and stress-related symptoms in functional medicine settings
• Monitoring adrenal function during critical illness
• Investigating amenorrhea, infertility, or polycystic ovary syndrome

Reference Ranges

Serum Cortisol — AM (drawn 7–9 AM) (µg/dL)

Serum Cortisol — PM (drawn 3–5 PM) (µg/dL)

24-Hour Urine Free Cortisol (UFC) (µg/24 hours)

Salivary Cortisol — AM (upon waking) (µg/dL)

These ranges vary between laboratories and should be interpreted in clinical context. Cortisol levels fluctuate throughout the day; an AM level is the most clinically meaningful single serum measurement because it represents the daily peak. A single random cortisol in the afternoon has limited diagnostic value unless it is very low (below 3 µg/dL, suggesting adrenal insufficiency) or being used to confirm a pattern with other testing.

Critical clinical thresholds for adrenal insufficiency: An AM cortisol below 3 µg/dL strongly supports adrenal insufficiency. An AM cortisol above 18–19 µg/dL effectively rules it out. Values between 3 and 18 µg/dL require ACTH stimulation testing for definitive diagnosis.

Testing Methods

Serum (Blood) Cortisol

The most common clinical measurement. Blood is drawn in the morning (7–9 AM) to capture peak cortisol. Results reflect total cortisol (bound + free). Advantages: precise, standardized, widely available. Limitations: single time point, reflects total rather than free cortisol, affected by CBG-altering conditions (pregnancy, oral contraceptives, liver disease), and subject to acute stress of venipuncture raising the level.

Salivary Cortisol

Salivary cortisol measures free, biologically active cortisol because saliva contains no CBG. It can be collected non-invasively at home at multiple time points, making it ideal for assessing the diurnal cortisol pattern. Collection is typically done upon waking, 30–60 minutes after waking (the cortisol awakening response or CAR), at noon, and at bedtime.

Late-night salivary cortisol (11 PM–midnight) is particularly valuable for screening Cushing's syndrome because cortisol should be at its nadir at this time — an elevated midnight salivary cortisol strongly suggests hypercortisolism. The Endocrine Society recommends late-night salivary cortisol as one of three first-line tests for Cushing's syndrome.

24-Hour Urinary Free Cortisol (UFC)

UFC integrates total cortisol excretion over 24 hours, capturing the complete diurnal variation. It is not affected by CBG levels and is not susceptible to acute stress-related spikes. Limitations: cumbersome collection process; incomplete collections (common) give falsely low results; high urine volume (greater than 5 liters/day) can cause false elevation even without hypercortisolism. UFC above 3 times the upper limit of normal is highly specific for Cushing's syndrome.

ACTH Stimulation Test (Cosyntropin Test)

The gold standard for diagnosing primary and secondary adrenal insufficiency. Synthetic ACTH (cosyntropin, 250 µg IV or IM) is administered, and cortisol is measured at 0, 30, and 60 minutes. A normal response is a peak cortisol above 18–20 µg/dL (threshold varies by assay). Failure to reach this threshold confirms adrenal insufficiency. The test distinguishes poor adrenal reserve from normal cortisol axis function but cannot discriminate primary from secondary adrenal insufficiency based on cortisol response alone — this requires simultaneous ACTH measurement (low ACTH suggests secondary/tertiary; high ACTH suggests primary).

Dexamethasone Suppression Test (DST)

Dexamethasone is a synthetic glucocorticoid that suppresses ACTH (and thus cortisol) in normal individuals through negative feedback. Failure to suppress confirms autonomous cortisol production:

• Overnight DST: 1 mg dexamethasone at 11 PM; cortisol drawn at 8 AM. Normal: cortisol suppresses to below 1.8 µg/dL. Cushing's: fails to suppress. Sensitive but not specific (false positives in depression, alcoholism, obesity, CRH-stimulant medications).
• 2-day low-dose DST: 0.5 mg dexamethasone every 6 hours for 48 hours. More specific than overnight DST.
• High-dose DST (8 mg): Used to differentiate pituitary-dependent Cushing's disease (cortisol suppresses) from adrenal tumors or ectopic ACTH secretion (cortisol does not suppress).

Cushing's vs. Addison's Disease

Cushing's Syndrome

Cushing's syndrome is defined by chronic exposure to elevated glucocorticoid levels, whether endogenous or exogenous. Exogenous Cushing's from long-term glucocorticoid therapy is the most common cause overall. Endogenous Cushing's syndrome is classified by etiology:

• Cushing's disease (65–70% of endogenous cases): ACTH-secreting pituitary adenoma; ACTH is elevated, driving bilateral adrenal hyperplasia
• Adrenal Cushing's (15–20%): Autonomous adrenal adenoma or carcinoma secreting cortisol independently; ACTH is suppressed
• Ectopic ACTH syndrome (5–10%): Non-pituitary tumor (most commonly small cell lung cancer, carcinoid tumors) secreting ACTH; often associated with profound hypokalemia and metabolic alkalosis

Untreated Cushing's syndrome significantly increases mortality from cardiovascular disease, infections, and thromboembolic events. Surgical resection of the causative lesion is the definitive treatment.

Addison's Disease (Primary Adrenal Insufficiency)

Addison's disease results from destruction of the adrenal cortex, causing deficiency of both cortisol and aldosterone. In developed countries, autoimmune adrenalitis accounts for approximately 70–90% of cases; other causes include tuberculosis (historically the most common cause globally), fungal infections, metastatic cancer, bilateral adrenal hemorrhage (Waterhouse-Friderichsen syndrome), and medications (ketoconazole, etomidate, mitotane).

Key features distinguishing primary from secondary adrenal insufficiency:

• Primary (Addison's): Both cortisol and aldosterone deficient; ACTH is elevated (causing hyperpigmentation); electrolyte abnormalities (hyponatremia, hyperkalemia) are prominent; requires replacement with both hydrocortisone AND fludrocortisone (mineralocorticoid)
• Secondary (pituitary) / Tertiary (hypothalamic): Only cortisol deficient (aldosterone axis intact, regulated by renin-angiotensin, not ACTH); no hyperpigmentation; electrolyte disturbances are mild; requires hydrocortisone alone

Adrenal crisis is a medical emergency — acute adrenal insufficiency precipitated by physiological stress (surgery, infection, injury) presenting with hypotension, vomiting, abdominal pain, and potentially fatal cardiovascular collapse. Treatment is immediate IV hydrocortisone 100 mg followed by continuous infusion, plus aggressive IV saline and glucose.

HPA Axis Dysfunction

Between the clear pathologies of Cushing's syndrome and Addison's disease lies a spectrum of subtler HPA axis dysregulation that does not meet diagnostic criteria for either condition but generates significant patient symptoms. This area is one of the most contested in medicine, primarily debated under the colloquial term "adrenal fatigue."

The "Adrenal Fatigue" Controversy

"Adrenal fatigue" — a term popularized by alternative medicine proponents to describe a state of diminished adrenal reserve from chronic stress — is not a recognized medical diagnosis and is not supported by the mainstream medical evidence base. The Endocrine Society explicitly states that "adrenal fatigue" as a clinical entity does not exist, noting that no rigorous studies confirm its existence and that applying this label may delay diagnosis of true conditions causing similar symptoms.

However, genuine HPA axis dysregulation is well-documented in research:

• Chronic stress and altered diurnal rhythm: Persistent psychosocial stress flattens the cortisol diurnal curve — the normal morning peak is blunted and nighttime values remain inappropriately elevated. This pattern is associated with fatigue, metabolic dysfunction, impaired immunity, and cardiovascular risk.
• Post-traumatic stress disorder (PTSD): Associated with low basal cortisol and exaggerated stress response — possibly representing HPA axis sensitization after trauma
• Chronic fatigue syndrome / ME-CFS: Multiple studies document a mild hypocortisolism pattern and flattened diurnal curve in a subset of patients
• HPA suppression after glucocorticoid withdrawal: Exogenous steroid use suppresses the HPA axis; recovery of normal axis function may take weeks to months after discontinuation

The critical clinical point is that symptoms of fatigue, sleep disturbance, difficulty handling stress, brain fog, and low energy — commonly attributed to "adrenal fatigue" — have many potential causes (thyroid disease, anemia, sleep apnea, depression, nutritional deficiencies, autoimmune conditions) that deserve systematic evaluation before attributing them to adrenal dysfunction.

Circadian Rhythm of Cortisol

Cortisol exhibits one of the most robust circadian rhythms in the human body, driven by the suprachiasmatic nucleus (SCN) in the hypothalamus and entrained to the light-dark cycle. Understanding this rhythm is essential for properly collecting and interpreting cortisol measurements.

Normal cortisol daily pattern:

• Midnight to 3 AM: Nadir — cortisol at its lowest; disruption of this low point is the most sensitive indicator of Cushing's syndrome
• 3–5 AM: Cortisol begins rising in anticipation of awakening, driven by increased ACTH pulses from the pituitary
• Awakening (cortisol awakening response, CAR): Within 20–30 minutes of waking, cortisol surges by 50–100% above the pre-waking value; this sharp morning spike is a key physiological signal promoting arousal, glucose mobilization, and immune modulation
• 8–9 AM: Daily peak of cortisol, typically 15–25 µg/dL in serum
• Noon to afternoon: Gradual decline through the afternoon
• Evening (5–8 PM): Cortisol has fallen to roughly 50% of morning peak
• Bedtime: Low levels; disruption of normal sleep with elevated evening cortisol is associated with insomnia, late-night eating, and metabolic dysfunction

The cortisol awakening response (CAR) deserves special mention. The robust morning spike is not simply a reflection of waking up — it is an actively regulated neuroendocrine response. A blunted CAR is associated with burnout, chronic fatigue, depression, and chronic stress; an exaggerated CAR may indicate anxiety or hypervigilance of the HPA axis.

Light exposure is the primary entrainer of cortisol rhythm. Morning bright light exposure (ideally natural sunlight within the first hour of waking) robustly amplifies the CAR and sets the cortisol rhythm for the day. Evening blue light exposure (screens) delays melatonin production and disrupts the normal cortisol decline, contributing to elevated evening cortisol and difficulty sleeping.

Stress Management and Cortisol Modulation

For individuals with stress-related HPA dysregulation, multiple evidence-based interventions can normalize cortisol patterns and improve subjective wellbeing:

Sleep Optimization

• Consistent sleep and wake times reinforce circadian entrainment of the cortisol rhythm
• Seven to nine hours of sleep per night; chronic sleep restriction of even 1–2 hours raises evening cortisol and impairs glucose metabolism
• Sleep apnea causes chronic nocturnal cortisol activation; treatment with CPAP normalizes cortisol patterns

Exercise

• Moderate-intensity aerobic exercise acutely raises cortisol but chronically improves HPA axis regulation and stress resilience
• Overtraining (excessive high-intensity exercise without adequate recovery) chronically elevates cortisol and suppresses anabolic hormones — a state sometimes called functional overreaching
• Morning exercise aligns with the natural cortisol peak and is generally better tolerated than late evening sessions

Mind-Body Practices

• Mindfulness-based stress reduction (MBSR): Multiple RCTs demonstrate reduction in cortisol levels and improved diurnal rhythm after 8-week programs
• Yoga: Regular practice lowers morning cortisol and flattens the stress response to psychological challenges
• Breathing exercises: Slow diaphragmatic breathing (4–6 breaths per minute) activates the parasympathetic nervous system and acutely lowers cortisol
• Cold exposure: Regular cold water exposure appears to improve HPA axis regulation in some studies, though evidence is early

Nutritional Factors

• Phosphatidylserine: 400–800 mg/day has been shown in multiple studies to blunt cortisol responses to exercise and psychological stress
• Ashwagandha (Withania somnifera): Adaptogenic herb with multiple RCTs demonstrating reductions in serum cortisol (by 14–28%) and perceived stress scores at doses of 300–600 mg/day of root extract
• Rhodiola rosea: Adaptogen studied for fatigue and HPA axis support; evidence for cortisol modulation is less robust than for ashwagandha
• Magnesium: Deficiency enhances cortisol release in response to stress; supplementation (200–400 mg/day) may buffer the HPA stress response
• Vitamin C: Adrenal glands are among the highest concentration tissues for ascorbic acid; high-dose vitamin C blunts cortisol responses after strenuous exercise
• Caffeine limitation: Caffeine is a potent stimulator of cortisol secretion; limiting consumption (especially after noon) reduces afternoon and evening cortisol

Social and Psychological Interventions

• Chronic social isolation significantly elevates cortisol; maintaining quality social connections is a potent cortisol-modulating intervention
• Cognitive behavioral therapy (CBT) for anxiety and depression normalizes HPA axis hyperreactivity
• Nature exposure ("forest bathing") has been associated in multiple studies with reduced cortisol, blood pressure, and sympathetic nervous activity

Back to Table of Contents

References

1. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008;93(5):1526–1540.
2. Bornstein SR, Allolio B, Arlt W, et al. Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2016;101(2):364–389.
3. Lightman SL, Conway-Campbell BL. The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration. Nat Rev Neurosci. 2010;11(10):710–718.
4. Dhabhar FS. Effects of stress on immune function: the good, the bad, and the beautiful. Immunol Res. 2014;58(2–3):193–210.
5. Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7(1):29–37.
6. Michaud K, Matheson K, Kelly O, Anisman H. Impact of stressors in a natural context on release of cortisol in healthy adult humans: a meta-analysis. Stress. 2008;11(3):177–197.
7. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255–262.
8. Monteleone P, Beinat L, Tanzillo C, Maj M, Kemali D. Effects of phosphatidylserine on the neuroendocrine response to physical stress in humans. Neuroendocrinology. 1990;52(3):243–248.
9. Birkett MA. The Trier Social Stress Test protocol for inducing psychological stress. J Vis Exp. 2011;(56):3238.
10. Sephton S, Spiegel D. Circadian disruption in cancer: a neuroendocrine-immune pathway from stress to disease? Brain Behav Immun. 2003;17(5):321–328.
11. Thorn L, Hucklebridge F, Evans P, Clow A. Suspected non-adherence and salivary cortisol stress responses. Psychoneuroendocrinology. 2006;31(10):1181–1188.
12. Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther. 2014;94(12):1816–1825.